May is National Brain Tumor Awareness Month. Driven by advancement in research, surgical techniques, genetic discoveries, and much more, it has never been a better time to take action on brain tumors. The National Brain Tumor Society (NBTS), an organization whose mission is to unrelentingly invest in, mobilize, and unite our community to discover a […]
A recent study, published in The Journal of the American Medical Association, an international peer-reviewed medical journal, found that patients with three or fewer metastatic brain tumors who received treatment with stereotactic radiosurgery (SRS) had less cognitive deterioration three months after treatment than patients who received SRS combined with whole brain radiation therapy (WBRT). For […]
A recent study published in the International Journal of Radiation Oncology • Biology • Physics, the official journal of the American Society for Radiation Oncology (ASTRO), found that cancer patients with limited brain metastases who are under 50 years old could benefit from stereotactic radiosurgery (SRS) without whole brain radiation therapy (WBRT). The study, “Phase […]
According to a study recently published in the scientific journal of the American Society for Radiation Oncology (ASTRO), cancer patients with limited brain metastases who are under the age of 50 could benefit from receiving stereotactic radiosurgery (SRS) without whole brain radiation therapy (WBRT). The study analyzed patient data from the three largest randomized clinical […]
During Brain Tumor Awareness Month in May, many people and organizations across the nation focus on spreading awareness about brain tumors through community-powered education and providing new opportunities to get involved. The following organizations provide numerous resources for brain tumor patients and their loved ones, including general information about brain tumors, extensive research and studies, […]
Two recent studies presented at the annual meeting of the European Association of Neurosurgical Societies (EANS) reinforced the benefits of using CyberKnife® radiosurgery to treat various neurological diseases. Dr. Alfredo Conti, a neurosurgeon, led the first study. Dr. Conti used CyberKnife to treat perioptic meningiomas, a type of benign brain tumor that arises from the […]
Each year, the American Cancer Society releases updated facts and figures about the forecast of cancer in the United States. Fortunately, it has been reported that the cancer death rate has been greatly reduced in the past 20 years thanks to early detection and cancer prevention methods. At Illinois CyberKnife, our primary cancers treated include tumors […]
The American Cancer Society estimates 9,230 cases of breast cancer will be diagnosed in Illinois this year, some of which may also be facing the spread of the disease to other organs. Patients with metastatic breast cancer often require a secondary or adjuvant treatment option for tumors that have spread to other parts of the […]
Community Event Round Up: Illinois CyberKnife Participates in ALA Healthy Lung Expo and Ride Janie Ride Illinois CyberKnife has been making rounds all over the community! We enjoy every opportunity to reach out to residents in our area and connect with cancer patients and their families. We caught up with locals at the American Lung […]
Illinois CyberKnife has treated more than 70 brain tumor cases since opening in November 2011, accounting for nearly 50 percent of the center’s patients last year. Illinois CyberKnife treats brain tumors with an advanced procedure called stereotactic radiosurgery (SRS) using CyberKnife® technology. During treatment, precisely targeted, high-dose radiation beams are delivered to the tumor from […]